{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T17:17:23Z","timestamp":1722100643121},"reference-count":34,"publisher":"Japan Society for Clinical Immunology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn.J.clin.Immun","Jpn. J. Clin. Immunol."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2177\/jsci.40.155","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T22:14:24Z","timestamp":1501020864000},"page":"155-159","source":"Crossref","is-referenced-by-count":5,"title":["Leptin and autoimmune disease"],"prefix":"10.2177","volume":"40","author":[{"given":"Yoshimasa","family":"FUJITA","sequence":"first","affiliation":[{"name":"Department of Hematology and Clinical Immunology, Kanazawa Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","unstructured":"1) Zhang, Y., et al.: Positional cloning of the mouse obese genes and its human homologue. <i>Nature<\/i>. <b>372<\/b>: 425-432, 1994."},{"key":"2","unstructured":"2) Sato, N., et al.: Pathophysiological significance of the obese gene product, leptin, in ventromedial hypothalamus (VMH)-lesioned rats: evidence for loss of its satiety effect in VMH-lesioned rats. <i>Endocrinol<\/i>. <b>138<\/b>: 947-954, 1997."},{"key":"3","unstructured":"3) Vaisse, C., et al.: Leptin activation of Stat3 in the hypothalamus of wild-type and <i>ob\/ob<\/i> mice but <i>db\/db<\/i> mice. <i>Nature Genet<\/i>. <b>14<\/b>: 95-97, 1996."},{"key":"4","unstructured":"4) Hoggard, N., et al.: Localization of leptin receptor mRNA splice variants in murine peripheral tissues by RT-PCR and in situ hybridization. <i>Biochem Biophys Res Commun<\/i>. <b>232<\/b>: 383-387, 1997."},{"key":"5","unstructured":"5) Cioffi, J.A., et al.: Novel B219\/OB receptor isoforms: possible roles of leptin in hematopoiesis and reproduction. <i>Nature Med<\/i>. <b>2<\/b>: 585-589, 1996."},{"key":"6","unstructured":"6) Kimura, M., et al.: T lymphopenia in obese diabetic (<i>db\/db<\/i>) mice is non-selective and thymus independent. <i>Life Sci<\/i>. <b>62<\/b>: 1243-1250, 1998."},{"key":"7","unstructured":"7) Sanchez-Margalet, V., et al.: Human leptin signaling in human peripheral blood mononuclear cells. <i>Cell Immunol<\/i>. <b>211<\/b>: 30-36, 2001."},{"key":"8","unstructured":"8) De Rosa, V., et al.: A key role of leptin in the control of regulatory T cell proliferation. <i>Immunity<\/i>. <b>26<\/b>: 241-255, 2007."},{"key":"9","unstructured":"9) Fujita, Y., et al.: Leptin inhibits stress-induced apoptosis of T lymphocytes. <i>Clin Exp Immunol<\/i>. <b>128<\/b>: 21-26, 2002."},{"key":"10","unstructured":"10) Amarilyo, G., et al.: Leptin promotes lupus T-cell autoimmunity. <i>Clin Immunol<\/i>. <b>149<\/b>: 530-533, 2013."},{"key":"11","unstructured":"11) Batra, A., et al.: Leptin: a critical regulator of CD4<sup>+<\/sup>T-cell polarization in vitro and in vivo. <i>Endocrinol<\/i>. <b>151<\/b>: 56-62, 2010."},{"key":"12","unstructured":"12) Procaccini, C., et al.: Leptin induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4<sup>+<\/sup> effector T cell responses. <i>J Immunol<\/i>. <b>189<\/b>: 2941-2953, 2012."},{"key":"13","unstructured":"13) Ma, L., et al.: Elevated serum leptin levels in patients with systemic lupus erythematosus. <i>Pharmazie<\/i>. <b>70<\/b>: 720-723, 2015."},{"key":"14","unstructured":"14) Liu, Y., et al.: A cutting edge: Fasting-induced hypoleptinemia expands functional regulatory T cells in systemic lupus erythematosus. <i>J Immunol<\/i>. <b>188<\/b>: 2070-2073, 2012."},{"key":"15","unstructured":"15) Fujita, Y., et al.: Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL\/Mp-lpr mice. <i>J Immunol<\/i>. <b>192<\/b>: 979-984, 2014."},{"key":"16","unstructured":"16) Margiotta, D., et al.: Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results. <i>Eur Rev Med Pharmacol Sci<\/i>. <b>20<\/b>: 636-641, 2016."},{"key":"17","unstructured":"17) Deng, J., et al.: Leptin exacerbates collagen-induced arthritis via enhancement of Tn17 cell response. <i>Arthritis Rheumatol<\/i>. <b>64<\/b>: 3564-3573, 2012."},{"key":"18","unstructured":"18) Reis, B.S., et al.: Leptin receptor signaling in T cells is required for Th17 differentiation. <i>J Immunol<\/i>. <b>194<\/b>: 5253-5269, 2015."},{"key":"19","unstructured":"19) Claycombe, K., et al.: A role for leptin in sustaining lymphopoiesis and myelopoiesis. <i>Proc Natl Acad Sci USA<\/i>. <b>105<\/b>: 2017-2021, 2008."},{"key":"20","unstructured":"20) Lam, Q.L.K., et al.: Leptin signaling maintains B-cell homeostasis via induction of Bcl-2 and Cyclin D1. <i>Proc Natl Acad Sci USA<\/i>. <b>107<\/b>: 13812-13817, 2010."},{"key":"21","unstructured":"21) Agrawal, S., et al.: Leptin activates human B cells to secrete TNF\u03b1, IL-6 and IL-10 via JAK2\/STAT3 and p38MAPK\/ERK1\/2 signaling pathway. <i>J Clin Immunol<\/i>. <b>31<\/b>: 472-478, 2011."},{"key":"22","unstructured":"22) Fujita, Y., et al.: Prevention of fasting-mediated bone marrow atrophy by leptin administration. <i>Cell Immunol<\/i>. <b>237<\/b>: 52-58, 2012."},{"key":"23","unstructured":"23) Otero, M., et al.: Changes in plasma levels of fat derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. <i>Ann Rheum Dis<\/i>. <b>65<\/b>: 1198-1201, 2006."},{"key":"24","unstructured":"24) Targonska-Stepniak, B., et al.: Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity. <i>Rheumatol Int<\/i>. <b>28<\/b>: 585-591, 2008."},{"key":"25","unstructured":"25) Hizmetli, S., et al.: Are plasma and synovial fluid leptin levels correlated with disease activity in rheumatoid arthritis? <i>Rheumatol Int<\/i>. <b>27<\/b>: 335-338, 2007."},{"key":"26","unstructured":"26) Olama, S., et al.: Synovial\/serum leptin ratio in rheumatoid arthritis: the association with activity and erosion. <i>Rheumatol Int<\/i>. <b>32<\/b>: 683-690, 2012."},{"key":"27","unstructured":"27) Xibille-Friedmann, D., et al.: Two-year follow-up of plasma leptin and other cytokines in patients with rheumatoid arthritis. <i>Ann Rheum Dis<\/i>. <b>69<\/b>: 930-931, 2010."},{"key":"28","unstructured":"28) La Cava, A., et al.: The weight of leptin in immunity. <i>Nat Rev Immunol<\/i>. <b>4<\/b>: 371-379, 2001."},{"key":"29","unstructured":"29) Busso, N., et al.: Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. <i>J Immunol<\/i>. <b>168<\/b>: 875-882, 2002."},{"key":"30","unstructured":"30) McMahon, M., et al.: High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidized lipids. <i>Ann Rheum Dis<\/i>. <b>70<\/b>: 87-95, 2007."},{"key":"31","unstructured":"31) Wislowska, M., et al.: Serum leptin in systemic lupus erythematosus. <i>Rheumatol Int<\/i>. <b>28<\/b>: 467-473, 2008."},{"key":"32","unstructured":"32) Xu, W.D., et al.: Association between leptin and systemic lupus erythematosus. <i>Rheumatol Int<\/i>. <b>34<\/b>: 559-563, 2014."},{"key":"33","unstructured":"33) Matarese, G., et al.: Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. <i>J Immunol<\/i>. <b>166<\/b>: 5909-5916, 2001."},{"key":"34","unstructured":"34) Kraszula, L., et al.: Evaluation of the relationship between leptin, resistin, adiponectin and natural regulatory T cells in relapsing-remitting multiple screlosis. <i>Neurol Neurochir Pol<\/i>. <b>46<\/b>: 22-28, 2012."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":["\u30ec\u30d7\u30c1\u30f3\u3068\u81ea\u5df1\u514d\u75ab\u75be\u60a3"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/40\/3\/40_155\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,29]],"date-time":"2017-07-29T04:30:27Z","timestamp":1501302627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/40\/3\/40_155\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.40.155","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}